March 15, 2018 • 0 Comments

Date & Time:
April 19, 2018 - April 20, 2018
MacEwan Event and Conference Centre, Main Campus, University of Calgary, 2500 University Drive NW, Calgary AB


This evidence-based course is designed to introduce family physicians, specialist physicians, pharmacists and nurse practitioners to new medications, new indications for older products and new guidelines for treatment. Current therapeutics controversies are examined and drug and non-drug therapeutic approaches for selected clinical conditions are presented.


  • identify new medications and new indications for “old” products

  • examine current therapeutic controversies

  • compare drug and non-drug approaches for selected clinical conditions

  • discuss the types of evidence used to support the prescribing of one drug instead of another in the same class of drugs


Family Physicians, Pharmacists, Specialist Physicians, Nurse Practitioners, Other healthcare professionals


Mainpro+ Group Learning – 13.5 credits
MOC Section 1 – 13.5 credits
Application for accreditation has been made to the
Canadian Council on Continuing Education in Pharmacy.
Program Number Pharmacists: 1180-2018-2310-C-P
Program Number Technicians: 1180-2018-2338-C-T


To register or to find out more information visit the University of Calgary Continuing Medical Education & Professional Development website.

Add a Comment

While The Alberta Rural Physician Action Plan (RPAP) endeavours to maintain the currency and accuracy of information published via electronic media, the information is subject to change. It is advisable that users ascertain the currency of information immediately prior to use. RPAP disclaims all responsibility for loss or damage which may arise from the use of social media. Links to external websites and Facebook and Twitter user accounts, and all other social media accounts, are provided as a convenience to users and such sites and associated content. Data presented by RPAP is for informational purposes only and is provided without warranty, either expressed or implied. We assume no liability for any decision made or action taken or not taken by anyone using or relying upon this data. For further information about data usage and reproduction please contact RPAP Research and Analysis.

Made by Ignition Industries, CMS by HiQSoft